This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Aran Labrijn, PhD
Principal Scientist, Antibody Research and Technology at Genmab


Dr. Aran F. Labrijn has been working in the field of recombinant antibodies for more than 20 years. He holds a PhD in molecular immunology from the University of Amsterdam (2004). In 2002, he joined Genmab where he is currently a principal scientist in the department of antibody research and technology with a focus on understanding antibody biology and Fc-engineering. These studies have led to the development of therapeutic antibody formats, including Genmab’s bispecific antibody technology platform (DuoBody®).

Agenda Sessions

  • New Approaches to Multispecific Antibody Treatment